2009
DOI: 10.1517/14728210902997939
|View full text |Cite
|
Sign up to set email alerts
|

Atrial-selective sodium channel block for the treatment of atrial fibrillation

Abstract: The pharmacological approach to therapy of atrial fibrillation (AF) is often associated with adverse effects resulting in the development of ventricular arrhythmias. As a consequence, much of the focus in recent years has been on development of atrial-selective agents. Atrial-selective sodium channel blockers have recently been shown to exist and be useful in the management of AF. This review summarizes the available data relative to current therapies, focusing on our understanding of the actions of atrial sel… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
67
0

Year Published

2010
2010
2016
2016

Publication Types

Select...
7
1

Relationship

2
6

Authors

Journals

citations
Cited by 33 publications
(68 citation statements)
references
References 116 publications
1
67
0
Order By: Relevance
“…One possible explanation for this effect is the state-dependent inhibition of Na + channels by amiodarone, which means that the binding of the drug is increased when the channel is in its inactivated state. As the resting membrane potential in atria is more depolarized than in ventricles, amiodarone is considered to block atrial Na + channels more potently than ventricular ones (Burashnikov et al 2008;Burashnikov and Antzelevitch 2009). One aim of the present study was to investigate whether dronedarone displays a similar atrial-selective inhibition of the fast Na + channel as amiodarone.…”
Section: Introductionmentioning
confidence: 94%
“…One possible explanation for this effect is the state-dependent inhibition of Na + channels by amiodarone, which means that the binding of the drug is increased when the channel is in its inactivated state. As the resting membrane potential in atria is more depolarized than in ventricles, amiodarone is considered to block atrial Na + channels more potently than ventricular ones (Burashnikov et al 2008;Burashnikov and Antzelevitch 2009). One aim of the present study was to investigate whether dronedarone displays a similar atrial-selective inhibition of the fast Na + channel as amiodarone.…”
Section: Introductionmentioning
confidence: 94%
“…[1, 33, 34] The more negative half-inactivation voltage and more positive RMP importantly reduce the fraction of resting channels in atria vs. ventricles at RMP. Because recovery from sodium channel block generally occurs predominantly during the resting state of the channel, accumulation of sodium channel block is expected to be greater in atria than in the ventricles.…”
Section: Discussionmentioning
confidence: 99%
“…[33–35] Available data suggest that binding affinity of the I Na blocker for a given state of the channel (i.e., open, inactivated, or resting) does not determine the drug’s atrial-selectivity. [33] The rate of dissociation of the drug from the sodium channel, however, appears to be a key factor. I Na blockers possessing rapid vs. slow unbinding kinetics tend to be highly atrial-selective (e.g., ranolazine, vernakalant, amiodarone).…”
Section: Discussionmentioning
confidence: 99%
“…Ranolazine is predominantly an open state blocker, whereas amiodarone and dronedarone are predominantly inactivate state block. Other drugs, such as quinidine or disopyramide, may inhibit both open and inactivated sodium channels to a similar extent but are not as safe as they dissociate from the sodium channels slowly, thus adding to the development of ventricular arrhythmias [59]. These ventricular arrhythmias are not observed in combination therapy with dronedarone or amiodarone and ranolazine because these drugs present rapid dissociation from the sodium channel thereby causing a predominantly atrial-selective sodium-channel inhibition [60].…”
Section: Safety and Tolerabilitymentioning
confidence: 99%